We have a new insulin
April 24, 2004
AVENTIS > Aventis Receives FDA Approval of its Rapid-Acting Insulin Analogue Apidra®
Not sure what this means for us as diabetics or pumpers, but it is intended for pump use, and it is a 15 minute meal insulin. However, I haven't been able to find any thing else on the profile. I figure the more tools we have -- especially since I'm allergic to humalog, the better.
And of course, the online pharmacy doesn't have it listed yet.
Apidra has been studied in clinical trials in adult patients with type 1 and type 2 diabetes. It is designed to be injected within 15 minutes before a meal or immediately after a meal (within 20 minutes after starting a meal). It is intended to be given by subcutaneous injection, or by continuous subcutaneous pump infusion.